NextFin news, On October 21, 2025, a multidisciplinary team of researchers from the University of Southern California (USC) Neurorestoration Center, California Institute of Technology (Caltech), Rancho Research Institute, University of Toledo, and the National Neuroscience Institute of Singapore announced the development of a groundbreaking wearable optical device capable of noninvasively measuring brain blood flow while distinguishing it from scalp blood flow. Published in the journal APL Bioengineering, the study titled "Assessing human scalp and brain blood flow sensitivities via superficial temporal artery occlusion using speckle contrast optical spectroscopy" details the device's design and validation.
The device employs speckle contrast optical spectroscopy (SCOS), a technique that illuminates tissue with coherent laser light and captures the dynamic speckle patterns created by moving red blood cells using a high-resolution camera. By analyzing the blurring of these speckles, the system quantifies blood flow and volume. The wearable system is integrated into a headband containing a laser source and seven detectors positioned at increasing distances from the source, enabling depth-sensitive detection of blood flow signals.
To validate that the device accurately measures cerebral blood flow rather than superficial scalp circulation, the researchers temporarily occluded the superficial temporal artery—a major scalp artery—by gentle pressure in 20 human participants. This occlusion significantly reduced signals detected by shallow detectors sensitive to scalp blood flow, while signals from deeper detectors, corresponding to brain blood flow, remained stable. The optimal detector placement was found to be approximately 2.3 centimeters from the laser source, balancing signal depth and noise reduction.
According to Dr. Charles Liu, MD, PhD, director of the USC Neurorestoration Center and co-senior author, "Tiny blood cells passing through the laser beam scatter light in a way that allows us to measure blood flow and volume in the brain. This device offers a simple, noninvasive, and affordable alternative to expensive imaging techniques like MRI and CT scans." Co-author Dr. Simon Mahler, PhD, emphasized the importance of this experimental validation, stating, "For the first time in humans, this evidence shows that SCOS can probe beyond scalp layers to access cerebral signals, a critical step toward clinical application."
This innovation addresses a longstanding challenge in optical brain imaging: the interference of scalp and skull blood flow signals that obscure cerebral measurements. Traditional methods relied heavily on simulations to estimate brain versus scalp signal contributions, but this study provides direct experimental evidence and a practical occlusion framework for device calibration.
From a clinical perspective, the ability to noninvasively and continuously monitor cerebral blood flow has profound implications. Stroke, traumatic brain injury (TBI), and vascular dementia are neurological conditions where timely assessment of cerebral hemodynamics is critical. Current gold-standard imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) are costly, require specialized facilities, and provide only episodic snapshots. This wearable SCOS device offers a portable, cost-effective solution that could enable real-time monitoring at the point of care or even in community settings.
Moreover, the device's design accounts for interindividual anatomical variability, such as differences in scalp and skull thickness, by leveraging multi-detector data and occlusion testing to personalize signal interpretation. This adaptability enhances measurement accuracy across diverse populations, a key consideration for broad clinical deployment.
Looking forward, the research team plans to refine the device further by integrating sensors for direct skin contact to improve signal fidelity and ease of use. They also aim to enhance image resolution and data quality through software improvements. The technology is already being employed by collaborators for stroke and TBI diagnosis, signaling a rapid translation from research to clinical application.
In the broader context of biomedical optics and neurological diagnostics, this development represents a significant leap. By enabling precise differentiation between scalp and brain blood flow signals, the device overcomes a critical barrier that has limited the clinical utility of optical spectroscopy methods. Its non-ionizing, noninvasive nature allows for repeated measurements without risk, facilitating continuous monitoring essential for acute neurological care.
Industry experts anticipate that this technology will catalyze new opportunities in wearable neurodiagnostics, potentially integrating with artificial intelligence (AI) and machine learning algorithms to enhance data interpretation, predictive analytics, and personalized treatment strategies. The convergence of advanced optical sensing and AI-driven analytics could transform neurological healthcare, making proactive brain health monitoring accessible and routine.
In summary, this novel wearable optical device validated through innovative experimental occlusion techniques offers a promising, practical tool for noninvasive cerebral blood flow measurement. It stands to significantly impact stroke risk assessment, brain injury detection, and dementia management, heralding a new era of accessible, real-time neurological diagnostics.
According to Genetic Engineering and Biotechnology News, this advancement is poised to overcome the limitations of existing expensive imaging modalities and enable widespread clinical adoption, improving outcomes for millions affected by neurological disorders.
Explore more exclusive insights at nextfin.ai.